drug resistance mutations for surveillance of transmitted hiv-1 drug-resistance 2009 update耐药突变为2009年传播hiv - 1耐药性监测更新.pdfVIP

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update 1 2 3 4 ´ 5 6 Diane E. Bennett , Ricardo J. Camacho , Dan Otelea , Daniel R. Kuritzkes , Herve Fleury , Mark Kiuchi , Walid Heneine7, Rami Kantor8, Michael R. Jordan9, Jonathan M. Schapiro6, Anne-Mieke Vandamme 10, Paul Sandstrom11, Charles A. B. Boucher 12,13, David van de Vijver 12, Soo-Yon Rhee6, Tommy F. Liu6, Deenan Pillay14, Robert W. Shafer6* 1 World Health Organization, Geneva, Switzerland, 2 Molecular Biology Laboratory, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal, 3 Molecular Diagnostics, ‘‘Prof. Dr. Matei Bals’’ Institute for Infectious Diseases, Bucharest, Romania, 4 Brigham and Women’s Hospital Harvard Medical School, Boston, Massachusetts, United States of ´ America, 5 Laboratoire de Virologie EA 2968, Universite de Bordeaux, Bordeaux, France, 6 Division of Infectious Diseases, Stanford University, Stanford, California, United States of America, 7 Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 8 Division of Infectious Diseases, Brown University, Providence, Rhode Island, United States of America, 9 Tufts University School of Medicine, Boston, Massachusetts, United States of America, 10 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium, 11 Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottowa, Ontario, Canada, 12 Department of Virology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands, 13 Department of Medical Microbiology, University